938055-75-5

Upstream product

• 552856-41-4 1-[2-azido-3-O-benzyl-2-deoxy-5-O-methanesulfonyl-4-C-(methanesulfonyloxymethyl)-β-D-erythro-pentofuranosyl]thymine 
• 407-25-0 trifluoroacetic anhydride 

Downstream Products

• 938055-76-6 1-(2-trifluoroacetylamino-3-O-benzyl-4-C-methanesulfonyloxyrnethyl-5-O-methanesulfonyl-2-deoxy-β-D-ribofuranosyl)-N6-benzoyladenine 
• 938055-78-8 benzoic acid 3-(6-benzoylamino-purin-9-yl)-7-benzyloxy-2-oxa-5-aza-bicyclo[2.2.1]hept-1-ylmethyl ester 
• 938055-82-4 methanesulfonic acid 3-(2-amino-6-benzyloxy-purin-9-yl)-7-benzyloxy-2-oxa-5-aza-bicyclo[2.2.1]hept-1-ylmethyl ester 
• 938055-77-7 (1R,3R,4R,7S)-7-benzyloxy-1-methansulfonyloxymethyl-3-(N₆-benzoyladenin-9-yl)-2-oxa-5-aza-bicyclo[2.2.1]heptane 
• 938055-83-5 [3-(2-amino-6-benzyloxy-purin-9-yl)-7-benzyloxy-2-oxa-5-aza-bicyclo[2.2.1]hept-1-yl]-methanol 
• 938055-81-3 methanesulfonic acid 3-(2-amino-6-chloro-purin-9-yl)-7-benzyloxy-2-oxa-5-aza-bicyclo[2.2.1]hept-1-ylmethyl ester 
• 938055-79-9 [3-(6-amino-purin-9-yl)-7-benzyloxy-2-oxa-5-aza-bicyclo[2.2.1]hept-1-yl]-methanol 
• 938055-80-2 methanesulfonic acid 5-(2-amino-6-chloro-purin-9-yl)-3-benzyloxy-2-methanesulfonyloxymethyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-furan-2-ylmethyl ester 

Relevant academic research and scientific papers

ADENOSINE RECEPTOR ANTAGONISTS

The present application discloses locked nucleoside compounds of the Formula I which act as antagonists of adenosine receptors, in particular the adenosine A3 receptor, and the use of such adenosine A3 receptor compounds in medicine, e.g. for the treatmen

Synthesis of 2′-amino-LNA purine nucleosides

The first reported synthesis of 2′-amino-LNA purine nucleosides via a transnucleosidation is accomplished enabling the preparation of oligonucleotides incorporating 2′-amino-LNA with all four natural bases. Copyright Taylor & Francis Group, LLC.